CRI is seeking protocol concepts for phase I/II or II studies from clinicians and academic researchers with the goal of advancing immunotherapies that will provide the greatest impact on patient outcomes.
Funding of up to $1M per study is available. CRI will prioritize selection of trials that address areas of high unmet need in cancer and seek mechanistic insights using deep correlative studies. To mazimize the impact of each clinical trial it funds, CRI will advise on selected studies to coordinate and optimize trial design and translational studies.
The deadline to submit an Initial Protocol Concept is December 1, 2022.
Please contact Ryan Godfrey at grants@cancerresearch.org for submission requirements and instructions on how to apply.
No comments:
Post a Comment